2022 ICD-10-CM Diagnosis Code D3A.0

Benign carcinoid tumors

    2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
  • D3A.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2022 edition of ICD-10-CM D3A.0 became effective on October 1, 2021.
  • This is the American ICD-10-CM version of D3A.0 - other international versions of ICD-10 D3A.0 may differ.
The following code(s) above D3A.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D3A.0:
  • C00-D49
    2022 ICD-10-CM Range C00-D49


    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
  • D3A
    ICD-10-CM Diagnosis Code D3A

    Benign neuroendocrine tumors

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Code Also
    • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
    Type 2 Excludes
    • benign pancreatic islet cell tumors (D13.7)
    Use Additional
    • code to identify any associated endocrine syndrome, such as:
    • carcinoid syndrome (E34.0)
    Benign neuroendocrine tumors
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
ICD-10-CM Codes Adjacent To D3A.0
D36.11 …… of face, head, and neck
D36.12 …… upper limb, including shoulder
D36.13 …… of lower limb, including hip
D36.14 …… of thorax
D36.15 …… of abdomen
D36.16 …… of pelvis
D36.17 …… of trunk, unspecified
D36.7 Benign neoplasm of other specified sites
D36.9 Benign neoplasm, unspecified site
D3A Benign neuroendocrine tumors
D3A.0 Benign carcinoid tumors
D3A.00 Benign carcinoid tumor of unspecified site
D3A.01 Benign carcinoid tumors of the small intestine
D3A.010 Benign carcinoid tumor of the duodenum
D3A.011 Benign carcinoid tumor of the jejunum
D3A.012 Benign carcinoid tumor of the ileum
D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion
D3A.02 Benign carcinoid tumors of the appendix, large intestine, and rectum
D3A.020 Benign carcinoid tumor of the appendix
D3A.021 Benign carcinoid tumor of the cecum
D3A.022 Benign carcinoid tumor of the ascending colon

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.